| __timestamp | Jazz Pharmaceuticals plc | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 85181000 | 396000000 |
| Thursday, January 1, 2015 | 135253000 | 364000000 |
| Friday, January 1, 2016 | 162297000 | 376000000 |
| Sunday, January 1, 2017 | 198442000 | 382000000 |
| Monday, January 1, 2018 | 226616000 | 432000000 |
| Tuesday, January 1, 2019 | 299726000 | 457000000 |
| Wednesday, January 1, 2020 | 335375000 | 463000000 |
| Friday, January 1, 2021 | 505748000 | 508000000 |
| Saturday, January 1, 2022 | 590453000 | 539000000 |
| Sunday, January 1, 2023 | 849658000 | 614000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, innovation is the key to staying ahead. Over the past decade, Zoetis Inc. and Jazz Pharmaceuticals plc have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, Zoetis consistently allocated a higher percentage of its resources to R&D, peaking at approximately 614 million in 2023, marking a 55% increase from 2014. Jazz Pharmaceuticals, while starting at a lower base, showed a remarkable growth trajectory, with R&D spending surging by nearly 900% over the same period, reaching around 850 million in 2023. This trend highlights Jazz's aggressive push towards innovation, potentially positioning it as a future leader in pharmaceutical advancements. As these companies continue to prioritize R&D, the industry can expect groundbreaking developments that could redefine healthcare solutions globally.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc: Who Invests More in Innovation?
Research and Development Investment: Jazz Pharmaceuticals plc vs CymaBay Therapeutics, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Ionis Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc or PTC Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Novavax, Inc.
R&D Spending Showdown: Jazz Pharmaceuticals plc vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Viridian Therapeutics, Inc.